Immunomedics, Inc.
(NASDAQ : IMMU)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.25%196.891.2%$506.00m
GILDGilead Sciences, Inc.
-0.64%73.120.9%$444.20m
BIIBBiogen Inc.
-0.53%329.181.3%$366.64m
CELGCelgene Corporation
-0.32%82.321.2%$329.41m
ILMNIllumina, Inc.
-1.87%315.673.5%$285.02m
REGNRegeneron Pharmaceuticals, Inc.
-1.76%377.392.6%$220.00m
ALXNAlexion Pharmaceuticals, Inc.
0.19%122.172.0%$209.14m
VRTXVertex Pharmaceuticals Incorporated
-1.22%179.101.9%$200.99m
SRPTSarepta Therapeutics, Inc.
0.90%131.6716.4%$167.91m
AAgilent Technologies, Inc.
-0.36%66.001.5%$153.99m
BMRNBioMarin Pharmaceutical Inc.
0.67%100.184.4%$129.21m
LGNDLigand Pharmaceuticals Incorporated
-1.02%200.5223.3%$107.04m
VKTXViking Therapeutics, Inc.
-2.35%14.120.9%$106.20m
NKTRNektar Therapeutics
0.25%49.035.6%$105.72m
NBIXNeurocrine Biosciences, Inc.
-0.67%110.745.1%$96.33m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.